|
Match
|
Document |
Document Title |
|
|
4000254 |
Fungimycin compositions
A method of increasing the overall effectiveness, including stability and gastrointestinal tolerability, of a polyenic macrolide selected from the class consisting of candicidin, fungimycin,...
|
|
|
3977992 |
Controlled release capsules
The disclosed substantially spherical capsules are particularly adapted for containing a liquid and have permeable or semi-permeable capsule walls. The capsule walls can comprise a first...
|
|
|
3951851 |
Process of producing aspirin-containing capsules
Process of producing aspirin-containing capsules which comprises (1) dispersing aspirin particles in a solution of a cellulose derivative in an organic solvent partially miscible with water; (2)...
|
|
|
3944064 |
Self-monitored device for releasing agent at functional rate
A delivery device for the controlled and continuous release of a useful agent at a functional rate is comprised of an erodible capsule housing a self monitored delivery device attached to a...
|
|
|
3939259 |
Coating composition and therapeutic preparation incorporating same
A therapeutic preparation consisting of particles containing a therapeutically active material are coated with a disintegratable coating comprising zein and shellac. A first group of particles...
|
|
|
3926817 |
Glidants and process for preparing the same
Improved glidants having excellent gliding properties, i.e., improving or eliminating those disadvantages encountered in the prior art, for example, capping of the finished pharmaceutical...
|
|
|
3917812 |
Compositions and method for diagnosing diseases of the pancreas
Diagnostic compositions containing fluorescein carboxylic acid esters comprising a hard gelatine capsule containing (a) a granulate and (b) an outer phase surrounding the granulate, wherein the...
|
|
|
3896108 |
Carboxyalkyl modified ethyl cellulose
Cellulose derivatives are described comprising a normally water-insoluble ethyl cellulose having 0.05 to 0.4 carboxyalkyl groups per anhydroglucose unit of the cellulose. These derivatives are...
|
|
|
3857933 |
PROCESS FOR THE MANUFACTURE OF A DRUG DOSAGE FORM PERMITTING CONTROLLED RELEASE OF ACTIVE INGREDIENT
A drug dosage form adaptable to further processing without secondary shap and permitting controlled release of a therapeutically active ingredient therefrom, said dosage form comprises a capsule...
|
|
|
3779783 |
MELTABLE COATING COMPOSITIONS, PARTICULARLY FOR FOODSTUFFS AND PHARMACEUTICAL PREPARATIONS
A coating composition especially suitable for foodstuffs and pharmaceutical preparations which comprises an acylated glyceride having an iodine value below 12 admixed in certain proportions with a...
|
|
|
3627695 |
INSOLUBILIZATION OF GELATIN-CONTAINING FILM BY CITRATE TREATMENT
A treatment process is disclosed for gelatin-containing or proteinaceous capsule wall materials and films wherein the capsules and films which include the proteinaceous materials therein are soaked...
|
|
|
3504082 |
MEDICAMENT ENTERIC-COATED WITH ACETONE-SOLUBLE METHYL CELLULOSE DICARBOXYLATES
|
|
|
3493407 |
PREPARATION OF MEDICINAL CAPSULES FROM HYDROXYALKYLCELLULOSE ETHERS
|
|
|
3432593 |
DELAYED AND SUSTAINED RELEASE TYPE PHARMACEUTICAL PREPARATION
|
|
|
3271450 |
2, 2'-(ethylenediimino)-di-1-butanols
|
|
|
3268576 |
Di-alkanoic acid esters of 2, 2'-(ethylenedhino)-di-1-butanols
|
|
|
3119742 |
Method of preparing sustained release pharmaceutical pellets and product thereof
|
|
|
3066075 |
Compositions comprising amphetamine and carboxymethyl cellulose in chemically combined form
|
|
|
2872374 |
Muscle-relaxing tranquilizer compositions
|
|
|
3582495 |
Title is not available
|